A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

NCT01714414 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Michael Hoelscher

Collaborators